Amedisys Q4 Loss Narrows - Quick Facts

(RTTNews) - Amedisys, Inc. (AMED) reported a fourth-quarter loss from continuing operations of $8.52 million, compared to a loss of $121.40 million, prior year. Loss per share from continuing operations attributable to stockholders was $0.26, compared to a loss of $3.50, last year. Adjusted loss from continuing operations attributable to stockholders per share was $0.05, for the period.

On average, 11 analysts polled by Thomson Reuters expected the company to report a loss per share of $0.01 for the quarter. Analysts' estimates typically exclude special items.

Net service revenue decreased to $303.50 million from $351.59 million. Analysts expected revenue of $295.02 million for the quarter.